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The Notch pathway is a crucial cell-fate regulator in the developing heart. Attention in the past centered on
Notch function in cardiomyocytes. However, recent advances demonstrate that region-specific endocardial
Notch activity orchestrates the patterning andmorphogenesis of cardiac chambers and valves through regu-
latory interaction with multiple myocardial and neural crest signals. Notch also regulates cardiomyocyte
proliferation and differentiation during ventricular chamber development and is required for coronary vessel
specification. Here, we review these data and highlight disease connections, including evidence that Notch-
Hey-Bmp2 interplay impacts adult heart valve disease and that Notch contributes to cardiac arrhythmia and
pre-excitation syndromes.Introduction
Notch is an evolutionarily conserved signaling pathway that regu-
lates cell-fate specification, differentiation, and patterning. Muta-
tions of Notch ligands and receptors are implicated in numerous
congenital and acquired human diseases (reviewed in Garg,
2006; Chabriat et al., 2009). Notch acts locally, specifying indi-
vidual fates among a group of equivalent neighboring cells or
directing a field of cells toward a given developmental fate. Notch
activity is crucial in organswith complex architecture, such as the
heart, that requires the coordinated development of multiple
parts. Functional studies in vertebrates demonstrate that Notch
is required for cardiovascular development (reviewed in Kokubo
et al., 2005; High and Epstein, 2008; Niessen and Karsan, 2008;
MacGrogan et al., 2010) and its importance for this process in
humans is demonstrated by the fact that mutations in several
Notch signaling elements underlie congenital cardiovascular
disease (HighandEpstein, 2008;MacGroganetal., 2011).Despite
the knowledge gained in the past years, the molecular mecha-
nisms and cellular processes that Notch regulates in the devel-
oping cardiovascular system remain only partially understood.
This review focuses on recent advances in the field of Notch
signaling in cardiac development and discusses them in the
context of the ‘‘developmental logic of Notch function’’ (Artava-
nis-Tsakonas and Muskavitch, 2010) and its role as a cell-fate
regulatory and patterning signal. We begin by describing the
elements of the Notch pathway and their expression during
mouse cardiac development. We then discuss how Notch
signaling patterns the embryonic endocardium, enabling
region-specific differentiation and critical interactions of the
endocardium (or its derived mesenchyme) with other cardiac
tissues (cardiac neural crest, myocardium), so that specialized
structures (cardiac valves and chambers) are generated. We
also discuss the importance of Notch in cell fate specification
during coronary vessel formation and the implication of Notch
in cardiac pathologies, including aortic valve disease, cardiomy-
opathy, and abnormalities of cardiac conduction.244 Developmental Cell 22, February 14, 2012 ª2012 Elsevier Inc.The Notch Signaling Pathway
Notch proteins are single-pass transmembrane receptors with
large extracellular regions (NECD) composed of 29–36 tandem
epidermal growth factor-like repeats, a shortermembrane-span-
ning portion, and an intracellular domain (NICD), which contains,
among other motifs, a transcriptional activation domain. When
released from the cell membrane, NICD can function as a tran-
scription factor (Kopan, 2002). Four Notch proteins (Notch1–
Notch4) have been identified in mammals (Kopan and Ilagan,
2009; Figure 1). Notch proteins are processed in the Golgi by
proteolytic cleavage by a furin-like convertase (Logeat et al.,
1998; S1 cleavage site, Figure 1). Modified Notch is then tar-
geted to the cell surface as a heterodimer held together by non-
covalent interactions. Once in the membrane, the NECD is avail-
able to interact with membrane-bound ligands of the Delta or
Serrate/Jagged families expressed by neighboring cells, and
cell-cell contact is required for signaling (Figure 1). Productive
ligand-receptor interaction depends on the activity of E3 ubiqui-
tin ligases such asmind bomb-1, which in the signaling cell ubiq-
uitylates the ligand and promotes its endocytosis (Itoh et al.,
2003). This event facilitates S2 cleavage of the receptor
(Figure 1). The remaining Notch fragment becomes susceptible
to cleavage by g-secretase (at the S3 site), resulting in release
of NICD, which translocates to the nucleus of the receiving cell
(Kopan and Ilagan, 2009). In the nucleus, NICD binds directly
to the transcription factor RBPJK/CSL/Su(H) (Jarriault et al.,
1995; Figure 1). NICD-RBPJK binding displaces corepressors
that repress target genes in the absence of Notch signaling
and allows recruitment of the transcriptional coactivator Master-
mind-like (MAML). Formation of the RBPJK-NICD-MAML ternary
complex leads to direct transcriptional activation of target
genes, including those encoding basic-helix-loop-helix (bHLH)
repressor transcription factors of the Hes and Hey (HESR) fami-
lies (Iso et al., 2003). The spectrum of immediate Notch targets is
large and several genes may be activated in parallel, including
those encoding repressor transcription factors like Snail1
Figure 1. The Notch Pathway
Membrane-bound Notch ligands (Dll1,3,4 and Jag1,2) are characterized by
a Delta/Serrate/Lag2 (DSL) motif (yellow) located in the extracellular domain.
The Notch receptor (Notch1-4) is processed at the S1 site by a furin protease,
sugar-modified by Fringe in the Golgi, and inserted into the membrane as
a heterodimer with a large extracellular domain (NECD). Ligand-receptor
interaction leads to two consecutive cleavage events (at S2 and S3 sites),
respectively carried out by an ADAM protease and presenilin, which release
the Notch intracellular domain (NICD). NICD translocates to the nucleus and
forms a transcriptional activation complex after binding toMastermind (MAML)
and CSL/RBPJk/Su(H). This ternary complex activates the transcription of
a set of target genes including Hes, Hey, and others.
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et al., 2001), or c-Myc, with a context-dependent activator or
repressor function (Weng et al., 2006). Other genes involved in
a variety of functions are also regulated by Notch (reviewed in
Andersson et al., 2011).
CardiacDevelopment andNotch Activity: AGeneralMap
Cardiac morphogenesis in the mouse begins at around E7.5
when, as the embryo folds, a subset of mesodermal cells
progressively distributes antero-laterally to form the cardiac
crescent at E8.0 (Figure 2A). This crescent contains two popu-
lations of precardiac cells, the first and second heart fields (FHF
and SHF, Figure 2A), that include progenitors of the first cardiac
tissues, the myocardium and endocardium. At this stage, N1ICD
(Del Monte et al., 2007) and the Notch ligands Dll4 (Duarte et al.,
2004) and Jag1 (our unpublished data) are detected in the prim-
itive E7.5 endocardium (Figure 2B), suggesting active Notch
signaling and early endocardial specification.
As development proceeds, the bilateral cardiac primordia
coalesce and fuse at the embryonic midline to form a single
primary heart tube at E8.0 (Figure 2C). This primitive heart
consists of two layers, an inner endocardium and outer myocar-
dium, separated by an extracellular matrix (ECM) termed cardiac
jelly (Figure 2D). At this stage, Jag1 expression is maintained in
the endocardium and is turned on in the primitive myocardium
(Loomes et al., 1999), while restricted endocardial expressionis displayed by Dll4, Notch2 (Timmerman et al., 2004), N1ICD
(Del Monte et al., 2007), and Notch4 (Uyttendaele et al., 1996;
Figure 2E).
The heart tube grows by incorporating SHF cells into the ante-
rior (arterial) and posterior (venous) poles. The heart tube simul-
taneously initiates a characteristic R-loop, or rightward bend,
and the initial anterior-posterior polarity transforms into a right-
left patterning (Figure 2F). In the E9.5 mouse heart, N1ICD
expression is relatively uniform in prospective valve endocar-
dium, namely, the endocardium lining the atrio-ventricular canal
(AVC) and the outflow tract (OFT, Figures 2Gand 2H). In contrast,
N1ICD expression in the ventricles is restricted to the endocar-
dium at the base of the developing trabeculae (Del Monte
et al., 2007), similar toDll4 (Grego-Bessa et al., 2007 and Figures
2G and 2H). Jag1 is strongly expressed in AVC endocardium and
myocardium (Loomes et al., 1999), while strong Notch2 expres-
sion is detected in chamber endocardium and transformed
mesenchymal cells (Loomes et al., 2002; Figures 2G and 2H).
At E9.5, a third cardiac tissue, the epicardium, develops
through the addition of cells originating from a transient structure
called the proepicardium, which arises from splanchnic meso-
derm posterior to the inflow region of the heart and expresses
Dll1, 4, Jag1, Notch2-4, and Hey1 (del Monte et al., 2011; Grie-
skamp et al., 2011 and Figure 2G). Epicardial cells, which
express Dll4, Jag1, Notch1, N2ICD, Notch3, and Hey1-L (del
Monte et al., 2011; Grieskamp et al., 2011), migrate and cover
the entire myocardial surface by E11.0. Epicardial cells then
undergo epithelial-mesenchymal transformation (EMT) to
generate subepicardial mesenchyme, expressing Dll4, Jag1,
N1ICD, and N2ICD (del Monte et al., 2011 and Figure 2G), which
differentiates into various lineages, including coronary smooth
muscle cells and cardiac interstitial cells (Mikawa and Gourdie,
1996; Christoffels et al., 2009).
Epicardium, myocardium, and endocardium are intimately
associated with one another and their interactions result in
a highly coordinated pattern of proliferation and differentiation
in the developing heart. In the mature four-chambered heart,
the endocardium lines the lumen of the cardiac chambers and
contributes to the atrio-ventricular (AV) valves and to a portion
of the OFT (semilunar) valves; the myocardium forms the
contractile tissue; and the epicardium contributes to the smooth
muscle cells of the coronary vasculature (Figure 2I), the subepi-
cardial mesenchyme, part of the AV valves, and the cardiac
fibroblasts. Several Notch elements are expressed in dynamic
patterns at these later stages and in the adult heart, suggesting
that Notch plays complex and reiterated roles in heart morpho-
genesis and homeostasis.
Endocardial Patterning and Lateral Induction
Notch patterns the early endocardium, which expresses many
Notch elements and whose interaction with the myocardium is
critical for cardiac development. Studies in mice show that
Notch loss of function (RBPJk or Notch1 mutants) impairs
expression of endocardial markers of chamber and valve tissue.
Thus, while early markers of endothelium (CD31/Pecam-1) and
myocardium (MLC2v, Irx4) are expressed, transcription of Irx5
and other endocardial markers is abrogated in Notch targeted
mutants, indicating that endocardial patterning is lost at a time
when myocardial patterning is unaffected (Timmerman et al.,Developmental Cell 22, February 14, 2012 ª2012 Elsevier Inc. 245
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Figure 2. Cardiac Development and Notch
Pathway Expression in the Mouse
(A) E7.5, cardiac crescent. Progenitor cell pop-
ulations of the first and second heart fields (FHF,
yellow; SHF, light blue) have fused in the midline of
the embryo.
(B) Jag1, Dll4, and N1ICD are expressed in the
developing endocardial tubes (blue).
(C) E8.0, heart tube stage. The approximate
contributions of FHF and SHF are shown.
(D) The heart tube has an outer myocardial layer
and an inner endocardial endothelium separated
by cardiac jelly (gray).
(E) Jag1 is expressed in the myocardium while
Dll4, N1ICD, Notch2, and Notch4 are expressed in
the endocardium.
(F) E9.5, looped heart. AVC formation separates
the atria from the ventricles. The approximate
contributions of FHF and SHF are shown.
(G) Valve primordia are formed between E9.5 and
E10.5. The diagram shows the contributions of
endocardium-derived mesenchyme to the AVC
and of endocardium-derived plus neural crest (NC)
mesenchyme to the OFT. Ventricular chamber
development begins with trabeculae formation in
the left and right ventricles. At this stage, the pro-
epicardium arises in the inflow region of the heart
and expresses Dll1,4; N2-4 and Hey1.
(H) In the E9.5–E10.5 heart, Jag1 is expressed in
chamber myocardium and endocardium; Dll4 and
N1ICD are expressed in valve and atrial endocar-
dium and at the base of trabecular endocardium.
Notch2 is expressed in chamber endocardium and
valve mesenchyme.
(I) E13.5-adult heart. The four chambers and four
valves are shown (1, tricuspid valve; 2, pulmonary
valve; 3, mitral valve; 4, aortic valve). The epicar-
dium covering the heart and expressing various
Notch elements is shown in gray and the coronary
vessels in yellow. Expression of Notch elements in
epicardium and coronary arteries is indicated. In
all panels the ventral aspect of the heart is shown
(anterior to the top). A, atria; AVC, atrio-ventricular
canal; LA, left atrium, LV, left ventricle; OFT,
outflow tract; RV, right ventricle.
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experiments, in contrast, show that ectopic N1ICD expression
in endocardium throughout the heart extends the uniform
N1ICD distribution observed in prospective valve tissue, thus
expanding valve patterning to ventricular endocardium (Luna-
Zurita et al., 2010).
A unique feature of Notch activity in the heart is that, unlike the
situation in the CNS and other tissues, Notch inactivation in the
embryonic endocardium results in decreased Dll4 ligand expres-
sion (Timmerman et al., 2004; Grego-Bessa et al., 2007), while
Notch activation expands Dll4 expression throughout this tissue
(Rutenberg et al., 2006; Watanabe et al., 2006; Luna-Zurita et al.,
2010). This implies the existence of a Notch-dependent positive
feedback loop regulatingDll4 expression in the embryonic endo-246 Developmental Cell 22, February 14, 2012 ª2012 Elsevier Inc.cardium. Furthermore, it suggests that
Notch in the endocardium functions by
a lateral induction mechanism whereby
endocardial cells behave as a develop-
mental field, and are specified together
(and not individually) as valve or chamberendocardium. These observations also apply to the vascular
endothelium, as the effect of Notch manipulation on Dll4 expres-
sion is the same (Luna-Zurita et al., 2010). In the CNS, individual
Dll1-expressing cells become neuroblasts and via lateral inhibi-
tion inhibit this fate in neighboring cells that downregulate ligand
expression via a negative feedback loop (Chitnis et al., 1995; de
la Pompa et al., 1997).
Establishing the Valve Territory
The AVC is located between the prospective atrial and ventric-
ular chamber regions (Figure 2F) and is a source of signals
promoting formation of the endocardial cushions, precursors
of the cardiac valves (Person et al., 2005; Aanhaanen et al.,
2011). Bmp2 is an essential patterning signal in AVC
Figure 3. Signals in Cardiac Patterning
(A) Top: wild-type Notch1 activity (red) is found in
the endocardium of the AVC, OFT, LA, and basal
region of trabeculae. Hey1, Hey2, and HeyL are
differentially expressed in chamber and AVC
endocardium. Myocardial Bmp2 expression (blue)
is confined to the AVC and OFT myocardium by
Hey1 (green) and Hey2 (brown), expressed in the
chambers. Middle: systemic Notch loss of func-
tion (Notch LOF) in RBPJk mutants leads to Hey
downregulation and ectopic Bmp2 expression in
the endocardium. Endocardial AVC and chamber
patterning is lost. Notch inactivation does not
affect myocardial patterning or the myocardial
expression domains of Hey1, Hey2, or Bmp2.
Bottom: Notch gain of function (Notch GOF) by
ectopic N1ICD expression in endocardium and
myocardium (Nkx2.5-Cre; RosaN1ICD). Expres-
sion of Hey1, 2, and HeyL expands throughout the
endocardium. Hey1 is expressed throughout the
myocardium (green), repressing Bmp2 in the AVC.
Valve patterning is lost in the myocardium and
expands throughout the endocardium.
(B) Pathway establishing chamber versus valve
domains in the developing heart. Cardiogenic
signals activate Tbx20 expression, which drives
Hey1 and Hey2 and represses Tbx2 expression in
chamber myocardium. Hey1 and Hey2 confine
Bmp2 expression to prospective valve tissue.
Tbx2 and 3 are activated by Bmp2 and restricted
to valve territory by Tbx20 and Hey. Forced Tbx2
expression represses Hey genes (dashed lines).
Color codes as in (A); abbreviations as in Figure 2.
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et al., 2000). Tbx2 is responsible for maintaining a primitive
myocardium phenotype in the AVC and throughout the inner
curvature of the heart (Christoffels et al., 2004). Cardiac-
specific deletion of Bmp2 causes a failure of AVC specification
(Ma et al., 2005), and mice lacking Tbx2 show defective AVC
patterning and ectopic expression of chamber-specific genes
(Harrelson et al., 2004; Aanhaanen et al., 2009). These studies
establish a Bmp2-Tbx2/3 regulatory axis specifying AVC
myocardium (Figure 3B; Yamada et al., 2000; Ma et al., 2005).
Ectopic expression experiments (Rutenberg et al., 2006; Wa-
tanabe et al., 2006; Luna-Zurita et al., 2010) have suggested
a critical role for Notch in confining Bmp2 expression to the
AVC myocardium (Figures 3A and 3B). Ectopic N1ICD expres-
sion in the myocardium activates the Notch target Hey1
throughout this tissue, which in turn represses Bmp2 and
Tbx2 in AVC, reflecting partial (Watanabe et al., 2006) or total
(Luna-Zurita et al., 2010) expansion of chamber territory at
the expense of the AVC (Figures 3A and 3B). Tbx20, which
represses Tbx2 (Singh et al., 2005), also impacts this pathway
and is required for chamber-specific gene expression and
differentiation upstream of Hey (Stennard et al., 2005; KokuboDevelopmental Cell 22,et al., 2007; Singh et al., 2005). The
functional requirement for Tbx20
extends to the adult heart, where it regu-
lates ion channel expression (Shen
et al., 2011). This regulatory interplay
between Tbx20, Tbx2, and Hey tran-
scription factors defines two develop-mental domains (chambers and valves) in the developing
myocardium (Figure 3B).
Although the results from N1ICD gain-of-function experiments
in myocardium have been informative (Rutenberg et al., 2006;
Watanabe et al., 2006; Luna-Zurita et al., 2010), Notch1 is not
normally expressed in the early and midgestation myocardium,
and inactivation of Notch signaling in RBPJk-targeted mutants
does not affect myocardial Hey1, Hey2, or Bmp2 expression
(Timmerman et al., 2004; Luna-Zurita et al., 2010). In the endo-
cardium, however, Notch1 does function via Hey genes to
repress Bmp2 (Luna-Zurita et al., 2010; Figure 3A,B). Ectopic
N1ICD in the endocardium activates Hey1, Hey2, and HeyL
(Luna-Zurita et al., 2010) and RBPJk mutant embryos show
strongly reduced endocardial Hey gene expression and Bmp2
activation.
Ventricular Pre-excitation and Arrhythmias
At late stages of cardiac development, AVC myocardium
partially regresses, although some derivatives contribute to the
muscular support of the AV valves, the conduction system
including the AV node, and muscular components of the left
ventricle. Recent studies suggest that alterations in NotchFebruary 14, 2012 ª2012 Elsevier Inc. 247
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relatively common forms of structural heart disease associated
with potentially lethal conduction defects (Aanhaanen et al.,
2011; Akazawa and Komuro, 2011; Rentschler et al., 2011).
Normally, the electrical activities of the atria and ventricles are
insulated from one another by the nonconducting annulus fibro-
sus, and impulses generated in the atria can travel to the ventri-
cles only via the relatively slow-conducting AV node. However, in
Wolff-Parkinson-White (WPW) syndrome and related disorders,
additional muscular pathways can electrically couple atria and
ventricles, allowing rapid AV conduction devoid of the physio-
logic protection provided by the AV node against ventricular
tachycardia induced by rapid atrial activity. This leaves affected
patients at risk of life-threatening arrhythmias. When NI1CD is
expressed in developing mouse myocardium (Mlc2v-Cre driver),
all resulting mice develop ventricular pre-excitation that mimics
WPW (Rentschler et al., 2011). Interestingly, a related phenotype
is seen in mice lacking the AVC patterning transcription factor
Tbx2 (Aanhaanen et al., 2011).
These results suggest that ventricular pre-excitation can arise
from deficient patterning of the AVC-derived myocardium,
whereby persistence of AVC myocardium results in strands of
myocardial tissue that electrically connect atria and ventricles,
explaining the etiology of cardiac pre-excitation syndromes
such asWPW. However, details of the underlying developmental
mechanisms remain to be explored. For example, although AVC
patterning occurs early in heart development (Harrelson et al.,
2004; Aanhaanen et al., 2009), Mlc2v-Cre;NICD mice do not
appear to have early AVC patterning defects (Rentschler et al.,
2011). Persistence of AVC myocardial strands is a late embry-
onic event, and ventricular pre-excitation is not evident until
postnatal life. Furthermore, Tbx2/3 expression is unaffected in
Mlc2v-Cre;NICD mice, suggesting that Notch activation does
not causeWPWas a result of Tbx2/3 repression. The relationship
between Notch and Tbx2/3 at late stages of AVC remodeling
remains to be defined, and the mechanisms by which Notch
can promote functional bypass tract formation (and whether it
does so in humans) will require further research.
Signal Integration in Cardiac Valve Development
Cardiac valve formation begins at around E9.5 in the mouse,
when myocardial signals from AVC and OFT regions instruct
adjacent endocardial cells to undergo EMT. During this process,
endocardial cells lose their endothelial cobblestone-like
morphology and become migratory mesenchyme, invading the
underlying extracellular matrix to form the cushion mesenchyme
(reviewed in Hinton and Yutzey, 2011).
In addition to its patterning role in the myocardium, Bmp2 is
a crucial EMT-inducing signal that via Alk3 and Alk6 receptor
activation in the endocardium, triggers EMT and cushion forma-
tion (Gaussin et al., 2002; Ma et al., 2005; Figure 4).
The endocardium is not passive during EMT but is the source
of crucial EMT-inducing signals, including Notch, whose
elements are expressed in AVC and OFT endocardium prior to
valve formation (Del Monte et al., 2007; Figures 2G and 2H). Tar-
geted inactivation of RBPJk or Notch1 results in severely hypo-
plastic endocardial cushions due to impaired EMT (Timmerman
et al., 2004). In E9.5 RBPJk mutants, AVC endocardial cells
display features of activated premigratory cells but fail to detach248 Developmental Cell 22, February 14, 2012 ª2012 Elsevier Inc.from one another and invade the cardiac jelly. RBPJk mutants
also show defective transforming growth factor beta 2 (Tgfb2)
transcription in endocardium and myocardium, suggesting
a non-cell-autonomous effect of Notch signaling on Tgfb2
expression (Timmerman et al., 2004). N1ICD-RBPJK activates
the EMT driver Snail1, whose expression is severely reduced in
RBPJk mutant AVC and OFT endocardium (Timmerman et al.,
2004). Loss of Snail1 expression prevents downregulation of
cadherin-mediated endocardial cell adhesion, and EMT is
blocked. Wild-type explants of AVC and OFT tissue are able to
undergo EMT when explanted onto a 3D-collagen gel (Markwald
et al., 1996). However, explants from Notch1 or RBPJkmutants,
or wild-type explants treated with a Notch-signaling inhibitor, do
not undergo EMT, indicating that Notch is crucial for this process
(Timmerman et al., 2004).
The importance of endocardial Notch signaling for EMT and its
role as a signal integrator was demonstrated by Notch1 gain of
function studies (Luna-Zurita et al., 2010). Endothelial- and
endocardial-specific N1ICD expression in the mouse embryo
leads to ectopic expression of Snail1, Snail2, and other EMT-
specific genes. In collagen gel explant assays, ventricular endo-
cardial cells from transgenic embryos unexpectedly transform
and behave like AVC endocardium, migrating over the gel
surface and expressing Snail1, Snail2, Tgfb2, Periostin, and
other mesenchyme markers, although they do not invade the
gel matrix. This partial, noninvasive EMT behavior becomes fully
invasive upon addition of BMP2 to the explant medium, suggest-
ing that EMT is indeed a two-phase process, involving indepen-
dent regulation of epithelial cell detachment and matrix invasion.
Notch1 signaling is attenuated after myocardial Bmp2 deletion,
and BMP2-induced ventricular EMT is reduced by Notch inhibi-
tion, suggesting that Bmp2 acts upstream of Notch in EMT
(Luna-Zurita et al., 2010).
Experiments with endothelial cells have suggested a mecha-
nism of myocardial Bmp2 and endocardial Notch1 signal inte-
gration during EMT: Bmp2-Alk3/6 signaling inhibits glycogen
synthase kinase-3b (Gsk3b) activity, which otherwise would
phosphorylate (and inhibit) Snail1. These data suggest that in
the prospective valve tissue, endocardial Notch1 promotes
Snail1 expression, while myocardium-derived Bmp2 activates
its endocardial receptors, triggering Snail1 expression and its
nuclear stabilization via Gsk3b inhibition (Luna-Zurita et al.,
2010). Thus, acquisition of the invasive phenotype by valve
mesenchyme involves Notch1- and Bmp2-induced Snail1
expression and Bmp2-mediated Snail1 nuclear accumulation,
leading to sustained expression of downstream mesenchymal
genes.
A recent report uncovered a Notch-dependent autocrine loop
in the AVC that activates expression of the soluble guanylyl
cyclase (sGC) heterodimer, the nitric oxide (NO) receptor (Chang
et al., 2011). Notch-RBPJK signals also promote NO production
via induction of the activin-A and PI3-kinase/Akt pathway. The
resulting increased NO signaling contributes to AVC EMT. This
finding is intriguing since it suggests a link between Notch, NO,
and valve disease (Figures 4A and 4B; see below).
Outflow Tract Development and Septation
The OFT is the arterial pole of the heart where the right and left
ventricles empty into the pulmonary trunk and the aorta,
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Figure 4. Tissue Interactions during Cardiac EMT
and Valve Morphogenesis
(A) Diagram of an E10 looped heart.
(B) Detail of the boxed area in (A) highlighting the OFT and
AVC endocardial cushions where EMT takes place and
valves form. Myocardium, red; endocardium, blue; extra-
cellular matrix, gray. Signals (arrows) from endocardium
and myocardium converge to trigger EMT. Migratory NC
mesenchyme invades the OFT region. Its interaction with
endocardial mesenchyme is crucial for valve morpho-
genesis.
(C) Diagram of an E12.5 heart showing the color-coded
expression of Notch elements during OFT and AAA re-
modeling. NC migrate from the dorsal neural tube around
the AAA and toward the OFT cushions. They will also
contribute to the SMC of the AAA.
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tions between endocardium, endocardial-derived mesenchyme,
cardiac and smooth muscle progenitors from the SHF, and
cardiac neural crest (NC) (Hutson and Kirby, 2007; Epstein,
2010). At midgestation, the single vessel emerging from the
looped heart, the truncus arteriosus, is remodeled under the
influence of invading NC and septates to form two vessels,
the aorta and the pulmonary trunk. At the same time, the OFT
rotates and aligns with the ventricles. If OFT alignment/rotation
is disturbed, the result is double-outlet right ventricle (DORV),
in which aorta and pulmonary trunk arise from the right ventricle,
an overriding aorta, or a related malalignment syndrome. Failure
of OFT septation results in persistent truncus arteriosus (PTA),
or, if partial septation occurs, an aorto-pulmonary window.
At E12.5, Notch elements are broadly expressed in the devel-
oping OFT (Loomes et al., 2002; High et al., 2007). Jag1 is ex-
pressed in NC-derived cells surrounding the aortic arch arteries
(AAA); Jag2 in the pharyngeal region, including cells around the
AAA; Dll1 only in OFT endocardium; and Dll4 in the endotheliumDevelopmental Cof AAA. Notch1 is expressed in the endothelium
lining the AAA and in the OFT endocardium;
Notch2 is expressed throughout the pharyngeal
mesenchyme and NC-derived cells surrounding
the AAA, similarly to Notch3; Notch4 is ex-
pressed in endothelial cells of the AAA
(Figure 4C). Notch inhibition in cardiac NC deriv-
atives was achieved by breeding mice express-
ing dominant-negative MAML (DNMAML) with
NC-specific Cre drivers (Pax3 and Wnt1) and
results in aortic arch patterning defects, pulmo-
nary artery stenosis, and ventricular septal
defects. Notch is also essential for differentiation
of cardiac NC precursors into smooth muscle
cells although it does not affect their proliferation
or migration into the OFT (High et al., 2007).
The cardiac progenitor driver Islet1-Cre and
the SHF-specific driver Mef2c-AHF-Cre were
bred with DNMAML or Jag1flox to abrogate
Notch signaling in cardiac progenitors, including
those of the SHF. These mice show complex
OFT and AAA defects including DORV and
PTA, indicating that Jag1 signaling is essential
in SHF derivatives (High et al., 2009). At E10.5,Isl1-Cre;DNMAML embryos show hypoplasia of the right
ventricle and OFT cushions, and the NC-derived mesenchyme
normally found within the OFT cushions is missing (High et al.,
2009). Pharyngeal explants containing distal OFT cultured with
a Notch inhibitor show reduced Fgf8 expression. Bmp4, a Fgf8
effector in OFT development (Park et al., 2008), is downregulated
in OFT cushions and myocardium of Islet1-Cre;DNMAML and
Islet1-Cre;Jag1flox/flox mutants (High et al., 2009). OFT explant
assays show that EMT is severely impaired in Islet1-Cre;
DNMAML mutants. This defect can be rescued by adding Fgf8
(High et al., 2009). These results suggest that Notch regulates
Fgf8 and Bmp4 expression in SHF myocardium, thereby
inducing EMT in adjacent endothelial cells (Figure 4B). The regu-
latory mechanism and the specific Notch elements, besides
Jag1, involved in OFT valve development remain to be studied.
In addition, detailed analysis of Islet1-Cre expression in pharyn-
geal mesoderm and neural crest and the functions of Notch
targets such as Hes1 (Rochais et al., 2009) in this process will
need to be pursued in the future.ell 22, February 14, 2012 ª2012 Elsevier Inc. 249
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During valve development, thinning and elongation of the valve
primordia leads to leaflet maturation, while the ECM is restruc-
tured into a highly stratified and VIC-dense mature matrix (re-
viewed in Hinton and Yutzey, 2011). A specific feature of OFT
(semilunar) valves morphogenesis is the infiltration by migratory
NC cells (Jiang et al., 2000; de Lange et al., 2004; Jain et al.,
2010). As previously discussed, Notch inhibition in SHF results
in complex OFT and AAA abnormalities reminiscent of those
caused by NC defects (High et al., 2009). Pax3 is amarker of pre-
migratory NC, and its inactivation causes defects in many NC
derivatives. Recent studies demonstrate that cardiac defects re-
sulting from loss of Pax3 include dysmorphic, thickened, and
functionally incompetent semilunar valves (Jain et al., 2011).
Interestingly, Notch inhibition in the SHF, which causes
secondary NC abnormalities, also affects semilunar valve devel-
opment. Thus, Islet1- or Mef2c-AHF Cre; DNMAML mice show
abnormal NC patterning in the OFT, indicated by the reduced
expression of postmigratory NC markers (Jain et al., 2011).
These findings suggest that Notch mediates signaling between
cardiac progenitors, including those of the SHF, and migrating
NC. This crosstalk probably occurs before these cell populations
have invaded the heart proper, while they are in apposition at
E9.5 in pharyngeal tissues (Jain et al., 2011). Interestingly, at
E17.5, the semilunar valve leaflets ofMef2c-AHF-Cre; DNMAML
embryos are 2.2 times bigger than those of wild-type littermates
and contain an excess of ECM. In utero assessment of cardiac
function by echocardiography shows moderate-to-severe aortic
insufficiency. These data demonstrate that Notch inhibition in
SHF progenitors leads to abnormal OFT valve morphogenesis
and function (Jain et al., 2011). NC is known to contribute to
OFT valve mesenchyme as early as E10.5, but these cells largely
disappear as development proceeds, so that by E17.5 few NC
derivatives remain (Jiang et al., 2000; de Lange et al., 2004).
Pax3-deficient NC mutants and SHF Notch mutants with defec-
tive NC patterning have hypocellular OFT cushions at early
stages, probably caused by reduced numbers of NC mesen-
chyme derivatives (High et al., 2009). However, by late gestation,
these mutants have hypercellular semilunar valves (Jain et al.,
2011). Semilunar valve morphogenesis is normally associated
with a gradual decrease in mesenchymal cell proliferation and
increased apoptosis (Hinton and Yutzey, 2011). Mef2c-AHF-
Cre or Islet-Cre; DNMAML embryos show deficient apoptosis
(Jain et al., 2011).
These data suggest that Notchmediates interactions between
NC- and endocardium-derived mesenchymal cells, triggering
the apoptosis that contributes to OFT valve remodeling (Jain
et al., 2011; Figure 4B). This illustrates some of the fundamental
developmental processes that are governed by Notch during
OFT valve morphogenesis, including proliferation, differentia-
tion, and apoptosis.
Cardiac Valve Disease: Recapitulation of an Embryonic
Regulatory Circuit
Abnormalities of valve remodeling are associated with develop-
ment of bicuspid aortic valves (BAV), a common adult cardiac
disease affecting 1%–2% of the population, which is associated
with important morbidity andmortality (Tzemos et al., 2008). BAV
is often undetected in childhood, but affected adults are prone to250 Developmental Cell 22, February 14, 2012 ª2012 Elsevier Inc.aortic valve calcification, regurgitation, and overall dysfunction
(Friedman et al., 2008). Calcific aortic valve disease (CAVD) is
the most common form of acquired valve disease in Western
societies (Goldbarg et al., 2007). Aside from BAV, the most
important factor associated with CAVD is age. As the obstructed
flow and improper valve function progresses, the left ventricle
has to increase its workload, which can lead to cardiac hyper-
trophy, dilatation, and heart failure. Examination of diseased
valves reveals lipid and calcium deposition in the leaflets, endo-
thelial cell activation, and inflammation (Otto, 2009).
NOTCH1 mutations occur in familial, nonsyndromic, auto-
somal-dominant CAVD associated with BAV (Garg et al.,
2005). Two types ofmutationwere found in this study. One family
has a premature stop codon in the NOTCH1 extracellular domain
while in another family, a frameshift mutation results in gross
alteration of the carboxy-terminus of the extracellular domain,
with the addition of 74 incorrect amino acids. NOTCH1 haploin-
sufficiency was suggested to be the mechanism underlying this
CAVD (Garg et al., 2005).Garg and coworkers showed that HEY1
and HEY2 repress the osteogenic master regulator RUNX2
through a physical interaction, suggesting that RUNX2 derepres-
sion may occur as a consequence of NOTCH1mutation in these
CAVD patients (Garg et al., 2005). Supporting an antiosteogenic
function, Notch1 was shown to repress valvular Bmp2 expres-
sion in adult murine aortic valve leaflets, and derepression of
Bmp2 following Notch1 inhibition caused the formation of
calcific nodules in valve interstitial cell cultures (Nigam and
Srivastava, 2009). Recentwork showed that Sox9, a transcription
factor downstream of Notch during valve development (Luna-
Zurita et al., 2010), is also Notch-responsive in the adult valve
(Acharya et al., 2011), and its downregulation may contribute
to valve calcification (Peacock et al., 2010).
Heterozygous Notch1 mutant mice do not show BAV but
develop signs of aortic valve calcification when fed a western
diet, although unlike human patients, they do not develop
stenosis (Nigam and Srivastava, 2009). In similar experiments,
heterozygous RBPJk or Notch1 mice were fed a high-fat diet
supplemented with vitamin D (Nus et al., 2011). In this setting,
only the heterozygous RBPJk mice develop CAVD with signifi-
cant hemodynamic disturbance. Pathological and molecular
analysis reveals macrophage infiltration, enhanced collagen
deposition, pro-osteogenic protein expression, and calcifica-
tion.
Notch inhibition in porcine VICs downregulates Hey1, acti-
vates osteogenic marker expression, and increases calcified
nodule formation (Nus et al., 2011). Despite the disparities
between the humans and mice, the diet-dependent mouse
genetic model of valve disease may prove very useful for
studying the molecular mechanism of CAVD and the potential
role of inflammation. The regulatory axis (Notch-Hey-Bmp2)
identified in the embryo is also at work in the adult and may be
subverted in congenital or acquired disease, leading to valve
calcification and stenosis. From the perspective of canonical
Notch function, this regulatory axis suggests that the role of
Notch in adult valve homeostasis includes the repression of
osteoblast cell fate in VICs.
On a final note, an involvement of Notch-NO pathway cross-
talk in BAV formation and valve disease is suggested by the
link between Notch and NO signaling during valve development
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Figure 5. Notch and Ventricular Trabeculation
The inner surface (endocardium) of the ventricular cavity is shown at the top,
and the outer surface (epicardium) at the bottom. Note the apposition of
endocardium and myocardium at the base of developing trabeculae, where
active Dll4-Notch1 signaling (strong red nuclei) predominates and decays
toward the apex (pink-white nuclei). Notch signals to the trabecular myocar-
dium to promote cardiomyocyte proliferation and differentiation (yellow and
blue arrows). Modified from Grego-Bessa et al. (2007).
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intriguing by the fact that mice deficient for endothelial NO syn-
thase have BAV (Lee et al., 2000) as do humans with NOTCH1
heterozygous mutations (Garg et al., 2005).Ventricular Trabeculation
During ventricular chamber development the myocardium differ-
entiates into two distinct layers: an outer compact zone and an
inner trabecular zone (Sedmera et al., 1997;Moorman and Chris-
toffels, 2003). Trabeculae are sheets of cardiomyocytes forming
muscular ridges lined by endocardial cells (Sedmera et al., 2000;
Moorman and Christoffels, 2003; Figure 5). Trabeculae are found
in all vertebrates and are a landmark in the initiation of ventricular
chamber formation (Moorman and Christoffels, 2003). Trabec-
ular cardiomyocytes and the overlying endocardium are in close
association, and communication between them regulates cardi-
omyocyte proliferation and differentiation. An early function of
trabeculae is to increase myocardial mass in the absence of
coronary circulation (Sedmera et al., 2000). As development
proceeds, trabeculae are remodeled and compressed, resulting
in increased thickness of the compact zonemyocardium. Failure
of trabeculae formation is embryonic lethal and failure to remodel
causes cardiomyopathy (Oechslin and Jenni, 2011).
Embryos lacking Notch1 or RBPJk, systemically or in the
endocardium, show defective trabeculation. Molecular analysis
of these mutants reveals that expression of endocardial and
myocardial trabecular differentiation markers is impaired, and
ventricular cardiomyocyte proliferation is inhibited. These find-
ings imply that endocardial Notch1 signaling is required forproliferation and differentiation of trabecular myocardium
(Grego-Bessa et al., 2007).
At least three signaling pathways essential for trabeculation
are affected in Notch mutants: Bmp10, Nrg1/ErbB, and Eph-
rinB2/EphB4. Bmp10 is expressed in trabecular myocardium
where it sustains proliferation (Chen et al., 2004). Standard or
endothelial-specific Notch inactivation markedly reduces
Bmp10 activity and trabecular myocytes proliferation. Pheno-
typic rescue of Notch mutant embryos upon incubation in
Bmp10-conditioned medium suggests that in trabecular myo-
cardiumNotchmodulates proliferation via Bmp10 (Grego-Bessa
et al., 2007).
Endocardial Nrg1 is crucial for trabeculation (Meyer and Birch-
meier, 1995) and signals to ErbB2-4 receptors, expressed on
myocardium (Lee et al., 1995). Nrg1 activity is reduced in Notch
mutants, and addition of Nrg1 to cultured Notchmutant embryos
rescue their cardiomyocyte differentiation defect (Grego-Bessa
et al., 2007).
The EphrinB2 ligand and EphB4 receptor signaling system are
also required for trabeculation (Wang et al., 1998). Endocardial
EphrinB2/EphB4 expression and activity is impaired in Notch
mutants and EphrinB2 is a direct transcriptional target of
N1ICD/RBPJk (Grego-Bessa et al., 2007). Additional studies
indicate that Nrg1 transcription is reduced in EphrinB2 mutants
while Bmp10 mutants show normal EphrinB2 and Nrg1 expres-
sion, suggesting that EphrinB2 acts upstream of Nrg1 and that
both molecules may act independently of Bmp10 during trabe-
culation.
These data allowed us to suggest a model (Figure 5) in
which Notch-mediated endocardium-myocardium interaction
promotes transition of primitive myocardium to trabecular
myocardium (EphrinB2- and Nrg1-dependent) and trabecular
cardiomyocyte proliferation is sustained by Bmp10 (Grego-
Bessa et al., 2007).
Epicardial Development and Cardiac Repair?
Initial analysis of the role of Notch in the epicardium and its deriv-
atives has been described in two recent reports (Grieskamp
et al., 2011; del Monte et al., 2011). In the first one, Tbx18-Cre;
RBPJkflox/flox mutants have been characterized (Grieskamp
et al., 2011). These mice show abnormal coronary vessels and
histology reveals dilation of the lumens of myocardially (arterial)
and subepicardiallly (venous) located vessels. Marker analysis
shows that large coronary arteries and veins are correctly spec-
ified. Moreover, the reduction of intramyocardial capillaries
suggests that coronary arteries and veins are expanded in the
mutants at the expense of capillaries (Grieskamp et al., 2011).
The authors conclude that the differentiation potential of mutant
EPDCs is compromised, since they are unable to differentiate
into smooth muscle cells (SMCs), suggesting that RBPJK-
dependent Notch signaling is required for perivascular cell differ-
entiation into SMCs (Grieskamp et al., 2011).
In the second report, Notch function in epicardial development
was studied with the driver line mWt1/IRES/GFP-Cre (Wt1Cre)
(del Monte et al., 2011). Wt1Cre;Notch1flox/flox embryos show
body and pericardial hemorrhages at E13.5 and hearts with
severely reduced and disorganized coronary vascular plexi.
Histology reveals that coronary vessels are particularly rare in
the compact myocardium zone where coronary arteries form,Developmental Cell 22, February 14, 2012 ª2012 Elsevier Inc. 251
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veins) is expanded. Coronary SMC marker expression is
reduced, as is the expression of EphrinB2, confirming that the
arterial nature of the affected vessels (del Monte et al., 2011).
These two reports indicate that Notch plays a key role in the
specification and differentiation of cell fates during epicardium
and coronary vessel development. The impaired coronary artery
development in Wt1-Cre;Notchflox/flox mice (del Monte et al.,
2011) might be primarily caused by a loss of coronary artery
progenitor specification. In Tbx18-Cre; RBPJkflox/flox mice,
coronary artery fate specification is unaffected but SMCdifferen-
tiation is impaired (Grieskamp et al., 2011). Notch has been
previously shown to regulate SMC differentiation in the systemic
vasculature (High et al., 2007; Feng et al., 2010), suggesting that
this might be a general role for Notch.
Recently, the epicardium has been considered as a potential
source for treating the damaged heart (Vieira and Riley, 2011).
The identification of a Notch-positive subepicardial progenitor
cell population expressing cardiac-related growth factors
(Russell et al., 2011) raised hopes about their role in cardiac
repair that have yet to be demonstrated.
Conclusions and Perspectives
NOTCH pathway mutations in humans result in very specific
cardiovascular developmental defects and syndromes. In this
review we have described studies that have defined the roles
of individual Notch elements during AVC and OFT formation
and morphogenesis, and in the development of the valves,
chambers, conduction system, and coronary vasculature. These
findings have important implications for understanding the
etiology of congenital cardiac defects that impact neonatal,
pediatric, and adult populations.
The available data on Notch function in the heart indicate that:
(1) Endocardial Notch, acting by lateral induction, regulates cell
fate specification and tissue patterning to define chamber versus
nonchamber (valve) domains; (2) Notch also regulates cell fate
specification in epicardium, coronary vessels, and the cardiac
conduction system; (3) endocardial Notch and myocardial
Bmp2 signaling converge on Snail1 to activate EMT, leading to
valve primordium formation; (4) endocardial Notch activity
modulates various myocardial signals (Tgfb2, Bmp10) required
for valve and trabecular development, suggesting that Notch
has a non-cell-autonomous effect in these distant cell popula-
tions; (5) during OFT valve morphogenesis Notch is required
for myocardial Fgf8 and Bmp4 expression and EMT and medi-
ates the communication between endocardium- andNC-derived
mesenchyme that results in the mature valve; (6) Notch influ-
ences cellular proliferation, differentiation, and apoptosis during
these processes; (7) the Notch-Hey-Bmp2 regulatory interplay in
the embryonic valves extends to the adult, and its disruption
causes aortic valve disease.
Despite important advances in recent years, the detailed
tableau of Notch-mediated regulation of cardiac development
has been only partially exposed. Future studies will need to deci-
pher in detail themechanisms of activation of the different tissue-
specific Notch elements, both in space and time, as well as to
relate these to clinical phenotypes. These challenges will require
sophisticated genetic tools and animal models, combined with
new expression and functional assays and imaging technolo-252 Developmental Cell 22, February 14, 2012 ª2012 Elsevier Inc.gies. We believe that increasing our knowledge of how Notch
regulates cardiac development will also help us to ascertain its
potential for cardiac repair.
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